For Boston in 2035: Take the “Red Line”

In this brief video made for Xconomy’s “Boston 2035” conference on June 17th, Tamr CEO and Co-Founder Andy Palmer lends his thoughts about the potential of information and bio technology to shape the future of work in Boston.
The core asset we have in Boston? It’s the “talent that’s available on the Red Line — the nexus now for entrepreneurship in Boston,” says Palmer.

It’s the place where all these people go to school … If we can put a commercial overlay of entrepreneurship and startups on top of that incredible quantity of talent coming out of those schools, I believe that we can create 3, 4 — or even 5 to 6 times the number of startups that we already have. And even if a fraction of those startups turn into big, independent public companies, we’re going to radically transform the employment landscape in Massachusetts.

Exciting stuff, and all part of Xconomy’s goal for “Boston 2035” of getting “a bunch of top minds together in the same room” to discuss “what, and who, will be the drivers of Boston’s innovation future?”
Representing the our family at the event will be Tamr advisor Frank Moss. Frank has had a 35-year career as a high-tech, biotech and health-tech entrepreneur. He is the co-founder and chairman of Twine Health and a co-founder of His startups include Stellar Computer, Bowstreet (acquired by IBM), Infinity Pharmaceuticals (INFI) and Bluefin Labs (acquired by Twitter). He was director of the MIT Media Lab from 2006 to 2011 and earlier was CEO and chairman of Tivoli Systems Inc., which he took public (1995) and subsequently merged with IBM (1996).
Access the conference agenda here, and register here.